Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-04-16

FDA Approved: BUSPIRONE HYDROCHLORIDE — Supplemental Application (Radha Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves a supplemental application for buspirone hydrochloride from Radha Pharmaceuticals, Inc., granting regulatory approval for this generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Buspirone hydrochloride (buspirone hydrochloride)

Snippet

SUPPL AP for BUSPIRONE HYDROCHLORIDE (BUSPIRONE HYDROCHLORIDE)